Rectal Cancer: Primary Staging and Assessment After Chemoradiotherapy

Seminars in Radiation Oncology

Volumn 21, Issue 3, 2011, Pages 169-177

  Evans, Jessica ^a   Patel, Uday ^a   Brown, Gina ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE;

CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; DIGESTIVE SYSTEM PERFORATION; ENDOSCOPIC ECHOGRAPHY; HUMAN; LYMPH NODE METASTASIS; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING; TREATMENT RESPONSE;

COMBINED MODALITY THERAPY; ENDOSONOGRAPHY; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PATIENT CARE PLANNING; PATIENT SELECTION; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PROGNOSIS; RECTAL NEOPLASMS; RISK ASSESSMENT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79957998013     PISSN: 10534296     EISSN: 15329461     Source Type: Journal    
DOI: 10.1016/j.semradonc.2011.02.002     Document Type: Review

References (75)

1. Merkel S., Mansmann U., Siassi M., et al. The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis 2001, 16:298-304.
2. Quirke P., Durdey P., Dixon M.F. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986, 1:996-999.
3. Dukes C.E. The classification of cancer of the rectum. J Pathol Bacteriol 1932, 35:323-332.
4. Hermanek P., Merkel S., Fietkau R., et al. Regional lymph node metastasis and locoregional recurrence of rectal cancer in the era of TNM surgery. Implications for treatment decisions. Int J Colorectal Dis 2010, 25:359-368.
5. Quirke P., Durdey P., Dixon M.F., et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986, 2:996-999.
6. Wibe A., Rendedal P.R., Svensson E., et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002, 89:327-334.
7. Hall N.R., Finan T., Al-Jaberi T., et al. Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence?. Dis Colon Rectum 1998, 41:979-983.
8. Adam I.J., Mohamdee M.O., Martin I.G., et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994, 344:707-711.
9. Talbot I.C., Ritchie S., Leighton M.H., et al. The clinical significance of invasion of veins by rectal cancer. Br J Surg 1980, 67:439-442.
10. Harrison J.C., Dean P.J., El-Zeky F., et al. From Dukes through Jass: Pathological prognostic indicators in rectal cancer. Hum Pathol 1994, 25:498-505.
11. Chapuis P.H., Dent O.F., Fisher R., et al. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 1985, 72:698-702.
12. Horn A., Dahl O., Morild I. The role of venous and neural invasion on survival in rectal adenocarcinoma. Dis Colon Rectum 1990, 33:598-601.
13. Rich T., Gunderson L.L., Lew R., et al. Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer 1983, 52:1317-1329.
14. Krasna M.J., Flancbaum L., Cody R.P., et al. Vascular and neural invasion in colorectal carcinoma. Incidence and prognostic significance. Cancer 1988, 61:1018-1023.
15. Ouchi K., Sugawara T., Ono H., et al. Histologic features and clinical significance of venous invasion in colorectal carcinoma with hepatic metastasis. Cancer 1996, 78:2313-2317.
16. Gunther K., Dworak O., Remke S., et al. Prediction of distant metastases after curative surgery for rectal cancer. J Surg Res 2002, 103:68-78.
17. Shepherd N.A., Baxter K.J., Love S.B. Influence of local peritoneal involvement on pelvic recurrence and prognosis in rectal cancer. J Clin Pathol 1995, 48:849-855.
18. Meyenberger C., Huch-Boni R.A., Bertschinger P., et al. Endoscopic ultrasound and endorectal magnetic resonance imaging: A prospective, comparative study for preoperative staging and follow up of rectal cancer. Endoscopy 1995, 27:469-479.
19. Palacios-Fanlo M., Ramirez-Rodriguez J., Aguilella-Diago V., et al. Endoluminal ultrasound for rectal tumors: Efficacy, sources of error and limitations. Rev Esp Enferm Dig 2000, 92:222-231.
20. Massari M., De Simone M., Cioffi U., et al. Value and limits of endorectal ultrasonography for preoperative staging of rectal carcinoma. Surg Laparosc Endosc 1998, 8:438-444.
21. Garcia-Aguilar J., Pollack J., Lee S.H. Local staging of rectal cancer with transrectal ultrasound and endorectal magnetic resonance imaging: Comparison with histological findings. Dis Colon Rectum 2000, 45:10-15.
22. Konishi F., Muto T., Takahashi H., et al. Transrectal ultrasonography for the assessment of invasion of rectal carcinoma. Dis Colon Rectum 1985, 28:889-894.
23. Kikuchi R., Takano M., Takagi K. Management of early invasive colorectal cancer risk of recurrence and clinical guidelines. Dis Colon Rectum 1995, 38:710-717.
24. Marone P., Petrulio F., de Bellis M., et al. Role of endoscopic ultrasonography in the staging of rectal cancer: A retrospective study of 63 patients. J Clin Gastroenterol 2000, 30:420-424.
25. Gualdi G.F., Casciani E., Guadalaxara A., et al. Local staging of rectal cancer with transrectal ultrasound and endorectal magnetic resonance imaging: Comparison with histological findings. Dis Colon Rectum 2000, 43:338-345.
26. Glaser F., Kuntz C., Schlag P., et al. Endorectal ultrasound for control of preoperative radiotherapy of rectal cancer. Ann Surg 1993, 217:64-71.
27. Herzog U., von Flue M., Tondelli P., et al. How accurate is endorectal ultrasound in the preoperative staging of rectal cancer?. Dis Colon Rectum 1993, 36:127-134.
28. Spinelli P., Schiavo M., Meroni E., et al. Results of EUS in detecting perirectal lymph node metastases of rectal cancer: The pathologist makes the difference. Gastrointest Endosc 1999, 49:754-758.
29. Marusch F., Koch A., Schmidt U., et al. Routine use of transrectal ultrasound in rectal carcinoma: Results of a prospective multicenter study. Endoscopy 2002, 34:385-390.
30. Brown G., Davies S., Williams G.T., et al. Effectiveness of preoperative staging in rectal cancer: Digital rectal examination, endoluminal ultrasound or magnetic resonance imaging?. Br J Cancer 2004, 91:23-29.
31. Augestad K.M., Lindsetmo R.O., Stulberg J., et al. International Rectal Cancer Study Group (IRCSG): International preoperative rectal cancer management: Staging, neoadjuvant treatment, and impact of multidisciplinary teams. World J Surg 2010, 34:2689-2700.
32. Muthusamy V.R., Chang K.J. Optimal methods for staging rectal cancer. Clin Cancer Res 2007, 13(suppl):6877-6884.
33. Thompson W.M., Halvorsen R.A., Foster W.L., et al. Pre-operative and postoperative CT staging of rectosigmoid carcinoma. AJR Am J Roentgenol 1986, 146:703-710.
34. Dworak O. Number and size of lymph nodes and node metastases in rectal carcinomas. Surg Endosc 1989, 3:96-99.
35. Maizlin Z.V., Brown J.A., So G., et al. Can CT replace MRI in preoperative assessment of the circumferential resection margin in rectal cancer?. Dis Colon Rectum 2010, 53:308-314.
36. Wolberink S.V., Beets-Tan R.G.H., de Haas-Kock D.F.M., et al. Conventional CT for the prediction of an involved circumferential resection margin in primary rectal cancer. Dig Dis 2007, 25:80-85.
37. Dighe S., Blake H., Koh M.D., et al. Accuracy of multidetector computed tomography in identifying poor prognostic factors in colonic cancer. Br J Surg 2010, 97:1407-1415.
38. Dighe S., Purkayastha S., Swift I., et al. Diagnostic precision of CT in local staging of colon cancers: A meta-analysis. Clin Radiol 2010, 65:708-719.
39. Brown G., Radcliffe R.G., Newcombe N., et al. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 2003, 90:355-364.
40. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: Results of the mercury study. Radiology 2007, 243:132-139. MERCURY Study Group.
41. Bissett I.P., Fernando C.C., Hough D.M., et al. Identification of the fascia propria by magnetic resonance imaging and its relevance to preoperative assessment of rectal cancer. Dis Colon Rectum 2001, 44:259-265.
42. Beets-Tan R.G.H., Beets G.L., Vliegen R.F.A., et al. Accuracy of MRI in prediction of tumor-free resection margin in rectal cancer surgery. Lancet 2001, 357:497-504.
43. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: Prospective observational study. BMJ 2006, 333:779. MERCURY Study Group, 14.
44. Smith N.J., Barbachano Y., Norman A.R. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 2007, 95:229-236.
45. Falk P.M., Gupta N.C., Thorson A.G., et al. Positron emission tomography for preoperative staging of colorectal carcinoma. Dis Colon Rectum 1994, 37:153-156.
46. Heriot A.G., Hicks R.J., Drummond E.G., et al. Does positron emission tomography change management in primary rectal cancer?. A prospective assessment. Dis Colon Rectum 2004, 47:451-458.
47. Habr-Gama A., Perez R.O., Nadalin W., et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: Long-term results. Ann Surg 2004, 240:711-717.
48. O'Neill B.D., Brown G., Heald R.J., et al. Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer. Lancet Oncol 2007, 8:625-633.
49. Chong I.Y., Brown G., Heald R.J. A multicenter phase II clinical study evaluating the deferral of rectal surgery following a continued response to preoperative chemoradiotherapy (CRT). J Clin Oncol 2010, 28. abstr TPS191.
50. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000, 92:205-216.
51. Rau B., Hunerbein M., Barth P. Accuracy of endorectal ultrasound after preoperative radiochemotherapy in locally advanced rectal cancer. Surg J Endod 1999, 13:980-984.
52. Gavioli M., Bagni A., Piccagli I., et al. Usefulness of endorectal ultrasound after pre-operative radiotherapy in rectal cancer. Comparison between sonographic and histopathologic changes. Dis Colon Rectum 2000, 43:1075-1083.
53. Napoleon B., Pujol B., Berger F., et al. Accuracy of endosonography in the staging of rectal cancer treated by radiotherapy. Br J Surg 1991, 78:785-788.
54. Pomerri F., Pucciarelli S., Maretto I., et al. Prospective assessment of imaging after preoperative chemoradiotherapy for rectal cancer. Surgery 2011, 149:56-64.
55. Kuo L.J., Chern M.C., Tsou M.H., et al. Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy. Dis Colon Rectum 2005, 48:23-28.
56. Chen C.C., Lee R.C., Lin J.K., et al. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy?. Dis Colon Rectum 2005, 48:722-728.
57. Allen S.D., Padhani A.R., Dzik-Jurasz A.S., et al. Rectal carcinoma: MRI with histologic correlation before and after chemoradiation therapy. AJR Am J Roentgenol 2007, 188:442-451.
58. Barbaro B., Fiorucci C., Tebala C., et al. Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology 2009, 250:730-739.
59. Dresen R.C., Beets G.L., Rutten H.J., et al. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. part I. Are we able to predict tumor confined to the rectal wall?. Radiology 2009, 252:71-80.
60. Koh D.M., Chau I., Tait D., et al. Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thin-section T2-weighted magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2008, 71:456-461.
61. Koh D.M., Padhani A.R. Diffusion-weighted MRI: A new functional clinical technique for tumour imaging. Br J Radiol 2006, 79:633-635.
62. Dzik-Jurasz A., Domenig C., George M. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 2002, 27:307-308.
63. Kim S.H., Lee J.M., Hong S.H., et al. Locally advanced rectal cancer: Added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology 2009, 253:116-125.
64. Sun Y.S., Zhang X.P., Tang L., et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: Preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 2010, 254:170-178.
65. Vliegen R.F., Beets-Tan R.G., Vanhauten B., et al. Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer?. Strahlenther Onkol 2008, 184:457-464.
66. Guillem J.G., Puig-La Calle J., Akhurst T., et al. Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. Dis Colon Rectum 2000, 43:18-24.
67. Denecke T., Rau B., Hoffmann K.T., et al. Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: Is there a benefit in using functional imaging?. Eur Radiol 2005, 15:1658-1666.
68. Amthauer H., Denecke T., Rau B., et al. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: Correlation with endorectal ultrasound and histopathology. Eur J Nucl Med Mol Imaging 2004, 31:811-819.
69. Capirci C., Rampin L., Erba P.A., et al. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging 2007, 34:1583-1593.
70. Kalff V., Duong C., Drummond E.G., et al. Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery. J Nucl Med 2006, 47:14-22.
71. Cascini G.L., Avallone A., Delrio P., et al. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med 2006, 47:1241-1248.
72. Haberkorn U., Strauss L.G., Dimitrakopoulou A., et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med 1991, 32:1485-1490.
73. Engenhart R., Kimmig B.N., Strauss L.G., et al. Therapy monitoring of presacral recurrences after high-dose irradiation: Value of PET, CT, CEA and pain score. Strahlenther Onkol 1992, 168:203-212.
74. Moore H.G., Akhurst T., Larson S.M., et al. A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients. J Am Coll Surg 2003, 197:22-28.
75. Buchpiguel C., Perez R., Ono C. Tumor downstaging in distal rectal cancer following neoadjuvant chemoradiation by sequential PET-CT. Preliminary results. J Nucl Med 2007, 48:392.